# Dexcom's €300M CGM manufacturing facility in Athenry, Ireland on track for 2026

Dexcom is building a state-of-the-art continuous glucose monitoring manufacturing facility in Athenry, Co Galway, Ireland, representing a €300 million investment over five years. The facility will create approximately 1,000 jobs and is on target for completion in 2026.

- Type: New facility
- Announced: 2024-10-25
- Where: Athenry, Co Galway, Ireland
- Value: $325.0M (300.0M EUR)
- Jobs: 1,000
- Starts operating: 2026
- Status: under construction
- Capacity: millions of CGM sensors per year
- Products: continuous glucose monitoring sensors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [DexCom](https://endata.com/companies/6670.md)

## Sources

- [businesspost.ie](https://www.businesspost.ie/commercial-reports/progress-on-major-dexcom-facility-on-target-for-2026/), 2024-10-25: "With the continued success of our Dexcom G7 in Europe, we are pursuing an ambitious growth strategy that requires increased manufacturing capacity to support our rapidly expanding European user base."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.